Vaxcyte Inc (NASDAQ: PCVX) on Tuesday, plunged -0.94% from the previous trading day, before settling in for the closing price of $85.94. Within the past 52 weeks, PCVX’s price has moved between $58.10 and $121.06.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 5.53%. With a float of $120.05 million, this company’s outstanding shares have now reached $124.43 million.
The extent of productivity of a business whose workforce counts for 254 workers is very important to gauge. In terms of profitability, gross margin is 2.95%, operating margin of -3662.28%, and the pretax margin is -3514.11%.
Vaxcyte Inc (PCVX) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Vaxcyte Inc is 3.68%, while institutional ownership is 108.53%. The most recent insider transaction that took place on Feb 05 ’25, was worth 450,369. In this transaction SVP, GEN COUNSEL & CORP SEC of this company sold 5,000 shares at a rate of $90.07, taking the stock ownership to the 28,222 shares. Before that another transaction happened on Feb 05 ’25, when Company’s Officer proposed sale 5,000 for $87.53, making the entire transaction worth $437,650.
Vaxcyte Inc (PCVX) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.03 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 5.53% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -4.61% during the next five years compared to -46.98% drop over the previous five years of trading.
Vaxcyte Inc (NASDAQ: PCVX) Trading Performance Indicators
Vaxcyte Inc (PCVX) is currently performing well based on its current performance indicators. A quick ratio of 17.88 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.68, a number that is poised to hit -1.11 in the next quarter and is forecasted to reach -4.38 in one year’s time.
Technical Analysis of Vaxcyte Inc (PCVX)
The latest stats from [Vaxcyte Inc, PCVX] show that its last 5-days average volume of 0.82 million was inferior to 1.15 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 27.32%. Additionally, its Average True Range was 3.79.
During the past 100 days, Vaxcyte Inc’s (PCVX) raw stochastic average was set at 17.48%, which indicates a significant increase from 16.12% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 42.41% in the past 14 days, which was lower than the 44.27% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $87.54, while its 200-day Moving Average is $88.09. Now, the first resistance to watch is $85.93. This is followed by the second major resistance level at $86.73. The third major resistance level sits at $87.96. If the price goes on to break the first support level at $83.90, it is likely to go to the next support level at $82.67. Assuming the price breaks the second support level, the third support level stands at $81.87.
Vaxcyte Inc (NASDAQ: PCVX) Key Stats
Market capitalization of the company is 10.61 billion based on 124,637K outstanding shares. Right now, sales total 0 K and income totals -402,270 K. The company made 0 K in profit during its latest quarter, and -103,120 K in sales during its previous quarter.
